Name Funds holding
in top 10
Growth Growth % Return since
31 Dec ‘20
276
3 +1 +50% 195%
277
3 +1 +50% 215%
278
3 +1 +50% 3.98%
PTGX icon
279
Protagonist Therapeutics
PTGX
$4.79B
3 +1 +50% 282%
280
3 +1 +50% 56.2%
281
3 +1 +50% 23.7%
282
3 +1 +50% 33%
283
3 +1 +50% 241%
284
3 +1 +50% 50.3%
285
3 +1 +50% 473%
IJJ icon
286
iShares S&P Mid-Cap 400 Value ETF
IJJ
$7.98B
22 +7 +47% 50.1%
287
19 +6 +46% 40.7%
288
16 +5 +45% 25.3%
289
13 +4 +44% 6.51%
290
13 +4 +44% 9.51%
291
13 +4 +44% 70.2%
292
13 +4 +44% 59.1%
293
36 +11 +44% 18.3%
294
10 +3 +43% 60.5%
295
10 +3 +43% 13.2%
296
10 +3 +43% 40.7%
297
10 +3 +43% 129%
298
10 +3 +43% 71.7%
299
17 +5 +42% 8.19%
300
38 +11 +41% 12.2%